Lotus Mallbris, based in Indianapolis, Indiana, United States, is currently a Vice President, Chief Development Officer, Global Clinical Development, Immunology Therapeutic Area at Eli Lilly and Company, bringing experience from previous roles at Eli Lilly and Company and Pfizer. Lotus Mallbris holds a 2019 - 2021 Master of Business Administration @ NYU Stern School of Business. With a robust skill set that includes Medicine, Dermatology, Pharmaceutical Industry, Clinical Trials, Clinical Development and more, Lotus Mallbris contributes valuable insights to the industry. Lotus Mallbris has 2 emails on RocketReach.